Perioperative changes of plasma circulating cell-free DNA in patients with coronary artery bypass graft and double valve replacement under cardiopulmonary bypass
|更新时间:2026-01-09
|
Perioperative changes of plasma circulating cell-free DNA in patients with coronary artery bypass graft and double valve replacement under cardiopulmonary bypass
Journal of Army Medical UniversityVol. 35, Issue 12, Pages: 1284-1287(2013)
Huang Jing,Xiao Yingbin.Perioperative changes of plasma circulating cell-free DNA in patients with coronary artery bypass graft and double valve replacement under cardiopulmonary bypass[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(12):1284-1287.
Huang Jing,Xiao Yingbin.Perioperative changes of plasma circulating cell-free DNA in patients with coronary artery bypass graft and double valve replacement under cardiopulmonary bypass[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(12):1284-1287.DOI:
Perioperative changes of plasma circulating cell-free DNA in patients with coronary artery bypass graft and double valve replacement under cardiopulmonary bypass
Objective To examine the changes of the concentration of plasma circulating cell-free DNA (cf-DNA) during cardiopulmonary bypass (CPB) open-heart surgery
and the changes of hepatic function
renal function and myocardial enzymes before and after operation
and to explore the significance. Methods Twenty-five patients admitted in our hospital from September 2012 to December 2012 wer
e enrolled. Thirteen patients with coronary artery disease underwent coronary artery bypass graft (CABG) were enrolled as a CABG group and 12 patients with rheumatic heart disease underwent double valve replacement (DVR) were enrolled as a DVR group. Venous blood was collected for the determination of hepatic function
renal function and myocardial enzymes
and plasma cf-DNA was detected by fluorescent semi-quantitative PCR. Results The concentration of plasma cf-DNA was elevated significantly during CPB in both groups
it peaked at the end of CPB
and decreased along with time extending. However
the concentration of plasma cf-DNA at 48 h after operation was still higher than that before CPB. The decrease of plasma cf-DNA in the CABG group was significantly faster than that in the DVR group (
P
0.05). The changes of plasma cf-DNA before and after operation were significantly correlated with total bilirubin and urea nitrogen (
P
0.01). Conclusion Plasma cf-DNA can monitor the injury of patients during CPB
and may be a valuable marker for the diagnosis and prediction of CPB complications.